Accent Microcell Limited (NSE:ACCENTMIC)

Market Cap	7.22B +42.4%
Revenue (ttm)	2.78B +6.0%
Net Income	346.64M +6.6%
EPS	15.66 -4.1%
Shares Out	21.04M
PE Ratio	21.91
Forward PE	n/a
Dividend	1.00 (0.29%)
Ex-Dividend Date	Sep 16, 2025

Volume	15,000
Average Volume	28,900
Open	336.75
Previous Close	340.00
Day's Range	336.50 - 347.90
52-Week Range	180.00 - 378.00
Beta	-0.08
RSI	55.53
Earnings Date	May 15, 2026

About Accent Microcell

Accent Microcell Limited manufactures, sells, and trades in cellulose-based excipients for the pharmaceutical industry in India and internationally. The company offers microcrystalline cellulose, powdered cellulose, microcrystalline cellulose spheres, silicified microcrystalline cellulose, crosscarmellose sodium, magnesium stearate, and microcrystalline cellulose with carboxy methyl cellulose. It also provides services, including supply chain management, on-time material delivery, customer assistance, and quality commitment. The company sells i...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 2001
• Employees: 192
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ACCENTMIC

Financial Performance

In fiscal year 2025, Accent Microcell's revenue was 2.65 billion, an increase of 7.84% compared to the previous year's 2.46 billion. Earnings were 330.63 million, an increase of 9.60%.